Bulls Keep Del Fris...
Health Care: Drugs
Allergan Inc. (AGN: NYSE)
$101.41 0.99 | 0.99%
05/17/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 5.81B | 5.42B | 4.92B | 4.50B |
| Cost of Sales | 656.00M | 614.50M | 575.80M | 608.90M |
| Gross Operating Profit | 5.15B | 4.80B | 4.34B | 3.89B |
| Selling, General, and Administrative Expenses | 2.27B | 2.25B | 2.63B | 1.92B |
| Research & Development | 989.60M | 902.80M | 804.60M | 706.00M |
| Operating Income before D & A (EBITDA) | 1.89B | 1.66B | 912.20M | 1.27B |
| Depreciation & Amortization | 250.80M | 261.80M | 284.20M | 288.30M |
| Interest Income | 6.70M | 6.90M | 7.30M | 7.00M |
| Other Income - Net | -23.10M | -500.00K | -16.40M | -9.60M |
| Special Income / Charges | -22.30M | -23.70M | -369.10M | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 1.60B | 1.37B | 249.50M | 925.40M |
| Interest Expense | 63.60M | 71.80M | 78.70M | 76.90M |
| Pre-Tax Income | 1.53B | 1.30B | 170.80M | 848.50M |
| Income Taxes | 430.80M | 361.60M | 165.90M | 224.70M |
| Minority Interest | 3.70M | 3.60M | 4.30M | 2.50M |
| Net Income From Continuing Operations | 1.10B | 0.00 | 0.00 | 623.80M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 1.10B | 0.00 | 0.00 | 623.80M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 1.10B | 934.50M | 600.00K | 621.30M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
1.13B | 28.30M | 369.40M | 674.70M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 1.10B | 0.00 | 0.00 | 623.80M |
| Basic EPS from Continuing Ops. | 3.64 | 3.07 | 0.00 | 2.05 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 3.64 | 3.07 | 0.00 | 2.05 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 3.64 | 3.07 | 0.00 | 2.05 |
| Basic Normalized Net Income/Share | 3.73 | n.a. | n.a. | 2.22 |
| EPS fr Continuing Ops. | 3.58 | 3.01 | 0.00 | 2.03 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 3.58 | 3.01 | 0.00 | 2.03 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 3.58 | 3.01 | 0.00 | 2.03 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
3.67 | n.a. | n.a. | 2.20 |
| Dividends Paid per Share | 0.20 | 0.20 | 0.20 | 0.20 |
Portfolios with AGN
- Portfolio NameUser Type
- ProRay Dalio - Bridgewater Ass...
- ContributorHigh Volume Technicals for ...
- ContributorTechnical Setups for the We...
- UserOil/Gas Feb 2012
- Contributor7 Stocks Set To Rise at Lea...
- UserCLUBCAR47 Portfolio 1
- UserLes's Picks
- ProBridger Management
- ContributorTop 20 Stocks With Large Se...
- ContributorRocket Stocks for the Week ...
Latest AGN Headlines from TheStreet
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Allergan Inc. (AGN): Today's Featured Drugs Laggard 05.08.13 | 05:05 pm
- Mad Money Uncovered: Allergan
05.08.13 | 06:05 am - 'Mad Money' Lightning Round: Discover Financial Is Cheap -- Buy It 05.07.13 | 06:05 am
- Cramer's 'Mad Money' Recap: Timing Is Everything 05.06.13 | 08:05 pm
- It's Pipeline That Matters Most 05.04.13 | 04:05 am
- Cramer's Top Stock Picks: AGN BP CRL PRU AIG 05.03.13 | 06:05 am
- Cramer's 'Mad Money' Recap: A New Dawn for Europe? 05.02.13 | 08:05 pm
- Allergan Rises On Unusually High Volume (AGN) 05.02.13 | 11:05 am
- Cramer's 6 Stocks in 60 Seconds: MA IP AA GILD PRU AGN (Update 1) 05.02.13 | 10:05 am
Press Releases for AGN
- Allergan, Inc. Announces Expiration Of Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals, Inc. And Intent To Exercise Top-Up Option To Effect A Short-Form Merger - Business Wire 03.01.13 | 09:03 am
- FDA Approves Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants - Business Wire 02.20.13 | 06:02 pm
- Allergan, Inc. And MAP Pharmaceuticals, Inc. Announce The Federal Trade Commission Has Granted Early Termination Of Waiting Period Under Hart-Scott-Rodino Act - Business Wire 02.07.13 | 09:02 am
- Allergan Reports Fourth Quarter 2012 Operating Results - Business Wire 02.05.13 | 09:02 am
- Allergan Commences Cash Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals - Business Wire 01.31.13 | 09:01 am
- The Law Firm Of Levi & Korsinsky, LLP Notifies Investors Of Claims Of Breaches Of Fiduciary Duty By The Board Of MAP Pharmaceuticals Inc. In Connection With The Sale Of The Company To Allergan Inc. - PR Newswire 01.25.13 | 03:01 pm
- MAP Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Allergan, Inc. - PR Newswire 01.23.13 | 11:01 am
- Allergan, Inc. To Acquire MAP Pharmaceuticals, Inc. - Business Wire 01.22.13 | 08:01 pm
- BOTOX(R) (onabotulinumtoxinA) Receives U.S. Food And Drug Administration Approval For The Treatment Of Overactive Bladder For Adults Who Have An Inadequate Response To Or Are Intolerant Of An Anticholinergic Medication - Business Wire 01.18.13 | 05:01 pm
- Allergan Announces Quarterly Conference Call - Business Wire 01.07.13 | 05:01 pm
Partner Headlines for AGN
- Apache, Windstream and Other Stocks Insiders Are Buying - Benzinga 04.06.13 | 12:04 pm
- Johnson & Johnson's Quest to Knock Botox off the Pedestal - Benzinga 03.22.13 | 02:03 pm
- Acadia Forges Forward With Pimavanserin - Seeking Alpha 03.13.13 | 09:03 am
- Icahn Enterprises, Sears Holdings and Other Stocks Insiders Are Buying - Benzinga 03.09.13 | 02:03 pm
- Valeant Earnings, Sales Top Estimates; Street Shrugs - Investor's Business Daily 02.28.13 | 05:02 pm
- Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for February 26, 2013 - NASDAQ 02.22.13 | 02:02 pm
- Why I Sold Allergan - Seeking Alpha 02.01.13 | 07:02 pm
- How To Play The Cosmeceutical Market - Seeking Alpha 12.25.12 | 09:12 am
- Buy MAP Pharmaceutical For 70% Upside - Seeking Alpha 11.26.12 | 09:11 am
- Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for November 19, 2012 - NASDAQ 11.15.12 | 02:11 pm
